1 Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
2 Institut d'Investigació Biomèdica Sant Pau, Barcelona, Spain.
Ann Am Thorac Soc. 2016 May;13(5):636-42. doi: 10.1513/AnnalsATS.201512-797OC.
Mucins are essential for airway defense against bacteria. We hypothesized that abnormal secreted airway mucin levels would be associated with bacterial colonization in patients with severe chronic obstructive pulmonary disease (COPD) Objectives: To investigate the relationship between mucin levels and the presence of potentially pathogenic micro-organisms in the airways of stable patients with severe COPD Methods: Clinically stable patients with severe COPD were examined prospectively. All patients underwent a computerized tomography scan, lung function tests, induced sputum collection, and bronchoscopy with bronchoalveolar lavage (BAL) and protected specimen brush. Patients with bronchiectasis were excluded. Secreted mucins (MUC2, MUC5AC, and MUC5B) and inflammatory markers were assessed in BAL and sputum by ELISA.
We enrolled 45 patients, with mean age (±SD) of 67 (±8) years and mean FEV1 of 41 (±10) % predicted. A total of 31% (n = 14) of patients had potentially pathogenic micro-organisms in quantitative bacterial cultures of samples obtained by protected specimen brush. Patients with COPD with positive cultures had lower levels of MUC2 both in BAL (P = 0.02) and in sputum (P = 0.01). No differences in MUC5B or MUC5AC levels were observed among the groups. Lower MUC2 levels were correlated with lower FEV1 (r = 0.32, P = 0.04) and higher sputum IL-6 (r = -0.40, P = 0.01).
Airway MUC2 levels are decreased in patients with severe COPD colonized by potentially pathogenic micro-organisms. These findings may indicate one of the mechanisms underlying airway colonization in patients with severe COPD. Clinical trial registered with www.clinicaltrials.gov (NCT01976117).
黏蛋白对于气道防御细菌至关重要。我们假设,在患有严重慢性阻塞性肺疾病(COPD)的患者中,异常分泌的气道黏蛋白水平与细菌定植有关。
研究稳定期严重 COPD 患者气道黏蛋白水平与潜在致病微生物存在的关系。
前瞻性检查临床稳定的严重 COPD 患者。所有患者均接受计算机断层扫描、肺功能检查、诱导痰采集以及支气管镜检查,包括支气管肺泡灌洗(BAL)和保护性标本刷。排除支气管扩张症患者。通过酶联免疫吸附试验(ELISA)评估 BAL 和痰中分泌型黏蛋白(MUC2、MUC5AC 和 MUC5B)和炎症标志物。
我们纳入了 45 例患者,平均年龄(±标准差)为 67(±8)岁,FEV1 预计值为 41(±10)%。通过保护性标本刷获得的样本定量细菌培养中,共有 31%(n=14)的患者存在潜在致病微生物。培养阳性的 COPD 患者 BAL(P=0.02)和痰中(P=0.01)MUC2 水平均较低。各组间 MUC5B 或 MUC5AC 水平无差异。较低的 MUC2 水平与较低的 FEV1(r=0.32,P=0.04)和较高的痰 IL-6(r=-0.40,P=0.01)相关。
潜在致病微生物定植的严重 COPD 患者气道 MUC2 水平降低。这些发现可能表明严重 COPD 患者气道定植的机制之一。临床试验在 www.clinicaltrials.gov 注册(NCT01976117)。